[Finished Printing? - Click Here to Return to Normal View]

NIDA Home > Researchers and Health Professionals > Blending Initiative > Buprenorphine Treatment

NIDA/SAMHSA Blending Initiative

Blending initiative graphicBuprenorphine Treatment: Training for Multidisciplinary Addiction Professionals

Primary Goal:

Opioid abuse and addiction (e.g., heroin, OxyContin) remains a critical national public health concern. To address this problem, the Buprenorphine Treatment Blending Team (also referred to as: 'Buprenorphine Awareness') developed a training package to disseminate information and enhance awareness among multi-disciplinary addiction professionals about buprenorphine treatment.

Blending Initiative - CD
 
Blending Initiative - brochure cover
Download brochure,
PDF format
216 Kb
Products:

Buprenorphine Treatment Blending Team products include:

  • Training manual for 6-hour classroom modules
  • PowerPoint presentation and CD
  • Annotated bibliography
  • Training Video
  • Research articles

All of these products have been completed and are available at: http://bupawareness.nattc.org/

Products Completed and Released: 2005

To obtain an overview about this Blending Team, objectives and products, download the brochure.

Blending Team Members:

NIDA:
Leslie Amass, Ph.D.
Gregory Brigham, Ph.D.
Eric Strain, M.D.

SAMHSA/ATTC:
Thomas Freese, Ph.D. (Lead)
Glenda Clare, M.A.
Gail Dixon, M.A.
Beth Finnerty, M.P.H.

Blending Initiative:

Need a drug treatment referral call 1.800.662.4357

Other Websites:



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment |



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, May 6, 2009. The U.S. government's official web portal